Table 2.
Treatment |
Sonovue |
Sonazoid |
Optison |
Definity |
|||||
---|---|---|---|---|---|---|---|---|---|
Ultrasound Power | low | high | low | high | low | high | low | high | |
IP | Tumor Volume (vs chemo) | * | **** | ◌ | ** | ○ | **** | *** | *** |
Hemoglobin total (vs chemo) | N/A | ○ | N/A | ◌ | N/A | ○ | N/A | ○ | |
Hemoglobin Average (vs chemo) | N/A | ○ | N/A | ○ | N/A | ○ | N/A | ○ | |
SO2 total (vs chemo) | N/A | ◌ | N/A | * | N/A | ○ | N/A | ○ | |
SO2 average (vs chemo) | N/A | ○ | N/A | ◌ | N/A | ○ | N/A | * | |
Increase in Tomato Lectin Staining | ○ | ○ | ● | ● | ● | ● | ● | ● | |
IV | Tumor Volume vs Chemo | ○ | ○ | * | *** | ○ | * | ○ | ○ |
% Vasculature vs Chemo | ○ | ○ | ** | ** | ○ | ◌ | ○ | * |
Summary of all changes observed sonoporations treatments vs treatments across high and low ultrasound power and both IP and IV treatment groups including the following parameters: tumor volume, hemoglobin total, hemoglobin average, SO2 total, SO2 average, Tomato Lectin staining and % vasculature. The following symbols for this table N/A, ◌, *, **, ***, ****, ●, ○ indicate p < .15, <.05, <.01, <.005, <.001, qualitative change and no change respectively